ORIGINAL Confidential

SANMOL FORTE TABLET

PROCESS VALIDATION REPORT

Document No. : VAL-PV/PVR/MB/068-B2 Batch #2 : OK8501

Revision No. : 00
Date : 02 JULY 2014
Product : SANMOL FORTE TABLET
Code : 01026
MS No. : PRO-ST/BRC/MB/087-SB; Rev. 00, PRO-
ST/BRC/MB/088-SB; Rev. 00
TS No. : SP-OJ-S-600; Rev. 02
Site : PT. CAPRIFARMINDO LABORATORIES
(Pharmaceutical Plant)
Jl. Industri Cimareme No. 08 Block H
Kabupaten Bandung Barat - Indonesia

Prepared by:
Function Name/Title Signature Date
Novita Purwanti /
Production
Process Validation Coordinator
Frisky Almuksiti /
Validation
Process Validation Engineer

Reviewed & Approved by:

Function Name/Title Signature Date
Mukti Wibowo /
Validation
Site Validation Coordinator
Herwanto /
R&D
Reviewed R&D Corp. General Manager
Quality Riny Yunita H. /
Control QC Manager
Khairudin /
Production
Plant Manager
Rismiatin /
QA Manager
Approved Quality
Sumardi /
Head of Quality

\\Cimareme\Release\Capri\Val\VAL-PV\Report\MB\068-B2 – Sanmol Forte Tablet Process Validation Report- R00.doc

ORIGINAL Confidential
Document No.VAL-PV/PVR/MB/068-B2 Rev. 00 Page 2 of 23
RPrepared, RReviewed, RReviewed, RReviewed,
Reviewed, Approved, Approved,

SUMMARY

SANMOL FORTE Tablet is one of toll manufactured product from PT. Sanbe Farma to PT.
Caprifarmindo Laboratories. Process validation of SANMOL FORTE Tablet batch number
OK8501 has been performed on October 28th, 2013 according to the process validation protocol
document number VAL-PV/PVP/MB/068 dated September 09th, 2013. The objective of this
validation is to ensure that the production process of SANMOL FORTE Tablet based on the batch
record for 120 kg batch size will produce high degree quality product consistently. The validation
covers mixing, granulating, compressing and stripping process of SANMOL FORTE Tablet.

The critical parameters in mixing and granulating process are mixer speed, mixing time, mass
appearence, identity, moisture content and assay.

During granulating process, adding water and mixing time over than from the written in the batch
record. This is because the massa have been yet to perfect wet. Statement noted in the batch
record.

The result of sampling on mixing and granulating process, could be seen at table below :

Loss on Drying
Sampling Point Loss on Drying (%) Acceptance Criteria Pass/Fail
A1 1.9 Pass
A2 1.9 Pass
A3 1.5 Pass
A4 1.6 Pass
T1 1.8 Pass
≤ 3.0 %
T2 1.6 Pass
T3 1.5 Pass
T4 1.5 Pass
B1 1.4 Pass
B2 1.4 Pass

Appearance and Identification of Bulk SANMOL FORTE Tablet

Parameter Tested Acceptance Criteria Result Pass/Fail
Appearance Powder Powder Pass
Color Light Yellow Light Yellow Pass
Odor Odorless Odorless Pass
Identification of
Positive Positive Pass
Acetaminophen

Assay of Acetaminophen
Sampling Assay Average Standard RSD
Pass/Fail
Point (97.0 – 105.0 %) (%) Deviation (≤ 5%)
Top (A) 97.9 99.8 2.1 2.1 Pass
Top (B) 102.4

\\Cimareme\Release\Capri\Val\VAL-PV\Report\MB\068-B2 – Sanmol Forte Tablet Process Validation Report- R00.doc

ORIGINAL Confidential
Document No.VAL-PV/PVR/MB/068-B2 Rev. 00 Page 3 of 23
RPrepared, RReviewed, RReviewed, RReviewed,
Reviewed, Approved, Approved,

Sampling Assay Average Standard RSD

Pass/Fail
Point (97.0 – 105.0 %) (%) Deviation (≤ 5%)
Middle (C) 99.1
Middle (D) 98.0
Bottom (E) 98.8
Bottom (F) 102.5

The critical parameters and testing points in compressing step are machine speed, compression
force, tablet weight, identity, uniformity of dosage units, hardness, thickness, friability,
disintegration time and related subtance comply with acceptance criteria.

The data on compressing process can be seen at table below :

Appearance and Identification of Core Tablet

Parameter Tested Acceptance Criteria Result Pass/Fail
Appearance Biconvex Round Tablet Biconvex Round Tablet Pass
Diameter 14 mm 14 mm Pass
Color Light Yellow Light Yellow Pass
Odor Odorless Odorless Pass
Sign Breakline-SANBE Breakline-SANBE Pass

Assay of Acetaminophen
Sampling Assay Average Standard RSD Pass
Point (97.0 – 105.0 %) (%) Deviation (≤ 5%) /Fail
Beginning 98.1
Middle 98.5 98.1 0.4 0.4 Pass
End 97.8

Uniformity of Dosage Units from Compressing Process

Sampling Assay Average Standard L1
Pass/Fail
Point (97.0 – 105.0 %) (%) Deviation (≤ 15.0%)
98.2
100.2
99.2
97.6
99.9
Beginning 98.5 1.1 2.7 Pass
96.4
98.1
98.7
98.5
98.8
Middle 99.6 98.7 1.3 3.0 Pass
96.8
99.4
97.4
\\Cimareme\Release\Capri\Val\VAL-PV\Report\MB\068-B2 – Sanmol Forte Tablet Process Validation Report- R00.doc
ORIGINAL Confidential
Document No.VAL-PV/PVR/MB/068-B2 Rev. 00 Page 4 of 23
RPrepared, RReviewed, RReviewed, RReviewed,
Reviewed, Approved, Approved,

Sampling Assay Average Standard L1

Pass/Fail
Point (97.0 – 105.0 %) (%) Deviation (≤ 15.0%)
98.8
100.9
98.1
97.8
98.3
100.0
98.2
98.3
98.0
98.0
97.3
End 97.5 0.6 2.5 Pass
96.8
97.7
96.7
96.8
96.9

Friability of Core Tablet

Result
Sampling Point Acceptance Criteria Pass/Fail
(%)
Beginning 0.3%
Middle ≤1% 0.2% Pass
End 0.2%

Disintegration Time of Core Tablet

Result
Sampling Point Acceptance Criteria Pass/Fail
(Minutes,Second)
Beginning 02’13”
Middle ≤ 15 minutes 01’25” Pass
End 01’24”

Hardness & Thickness of Core Tablet

Weight Hardness Thickness
Sampling Point
(776 – 824 mg) (8 – 11 kg/cm2) (6.0 ± 0.3 mm)
A 803 10 5.8
B 800 10 5.7
C 801 10 5.8
D 802 10 5.8
E 805 10 5.8

\\Cimareme\Release\Capri\Val\VAL-PV\Report\MB\068-B2 – Sanmol Forte Tablet Process Validation Report- R00.doc

ORIGINAL Confidential
Document No.VAL-PV/PVR/MB/068-B2 Rev. 00 Page 5 of 23
RPrepared, RReviewed, RReviewed, RReviewed,
Reviewed, Approved, Approved,

Weight Hardness Thickness

Sampling Point
(776 – 824 mg) (8 – 11 kg/cm2) (6.0 ± 0.3 mm)
F 799 10 5.8
G 803 9 5.8
H 803 9 5.8
I 799 10 5.7
J 800 10 5.8

Related Subtances
Acceptance Criteria Result Pass/Fail
peak area 4-aminofenol sample ≤ peak area
MS Pass
4-aminofenol 3rd solution (0.1%)
peak area 4-cloroasetanilida sample ≤ peak
MS Pass
area 4-cloroasetanilida 4th solution (10 bpj)
nothing peak area contamination over than
MS Pass
main peak area 2nd solution (0.25%)

Dissolution of Core Tablets

Acceptance
Sampling Point Assay (%) Average (%) Pass/Fail
Criteria
Beginning 95.6 Pass
> 85% (Q+5) in 45
Middle 91.7 94.5 Pass
minutes
End 96.3 Pass

The critical parameters and testing points in stripping step are temperature roller and leakage test.
All critical parameters comply with specification and no one leakage on stripping process.

All critical point and testing result comply with the acceptance criteria. Based on the described
data above, process validation of SANMOL FORTE Tablet batch number OK8501 has passed the
test parameter of finished product. Therefore the result of this validation is PASS.

RECOMMENDATION
The batch record can be implemented for routine production.

TABLE OF CONTENTS

\\Cimareme\Release\Capri\Val\VAL-PV\Report\MB\068-B2 – Sanmol Forte Tablet Process Validation Report- R00.doc

ORIGINAL Confidential
Document No.VAL-PV/PVR/MB/068-B2 Rev. 00 Page 6 of 23
RPrepared, RReviewed, RReviewed, RReviewed,
Reviewed, Approved, Approved,

SUMMARY.......................................................................................................................................2
1. OBJECTIVE................................................................................................................................8
2. SCOPE.........................................................................................................................................8
3. VALIDATION TEAM..................................................................................................................8
3.1. Team Member.....................................................................................................................8
3.2. Responsibilities...................................................................................................................8
3.2.1. Production Department.........................................................................................8
3.2.2. QC Department.....................................................................................................9
3.2.3. QA Department.....................................................................................................9
3.2.4. Validation Department..........................................................................................9
3.2.5. R&D Department..................................................................................................9
3.2.6. Engineering Department.....................................................................................10
3.2.7. PPIC Department................................................................................................10
4. PROCESS VALIDATION STAGE............................................................................................10
4.1. Responsible Personnel......................................................................................................10
4.2. Starting Material................................................................................................................10
4.2.1.Formula.....................................................................................................................10
4.2.2.Specification & Test Procedure Number of Raw Materials......................................10
4.2.3. Specification & Test Procedure Number of Packaging Materials............................11
4.2.4. Specification & Test Procedure Number Finished Product.....................................11
4.2.5. Machines/ Equipments.............................................................................................11
4.3. Room Condition................................................................................................................12
4.4. Process Schematic Flow....................................................................................................13
4.5. Production Process, Critical Parameter, Testing Point and Analysis Method...................14
4.6. Sampling Plan...................................................................................................................17
4.6.1. Sampling in FBD Jaw Chuang............................................................................17
4.6.2. Sampling in BOHLE...........................................................................................18
5.6.1. Sampling During Tablet Pressing.......................................................................18
5.6.2. Sampling during Stripping..................................................................................19
4.7. Acceptance Criteria...........................................................................................................20
5. CONCLUSION OF THE PROCESS VALIDATION................................................................20
The result of comparison between the actual yield and theoretical yield of SANMOL FORTE

\\Cimareme\Release\Capri\Val\VAL-PV\Report\MB\068-B2 – Sanmol Forte Tablet Process Validation Report- R00.doc

ORIGINAL Confidential
Document No.VAL-PV/PVR/MB/068-B2 Rev. 00 Page 7 of 23
RPrepared, RReviewed, RReviewed, RReviewed,
Reviewed, Approved, Approved,

Tablet batch number OK8501 is 98.3 %...................................................................................20

6. DISCUSSION............................................................................................................................20
7. RECOMMENDATION..............................................................................................................20
8. DECISION.................................................................................................................................21
9. PROPOSE OF REVALIDATION..............................................................................................21
10. LISTS OF ENCLOSURE..........................................................................................................22
11. DEVIATION REPORT..............................................................................................................22
12. REVISION HISTORY...............................................................................................................23

\\Cimareme\Release\Capri\Val\VAL-PV\Report\MB\068-B2 – Sanmol Forte Tablet Process Validation Report- R00.doc

ORIGINAL Confidential
Document No.VAL-PV/PVR/MB/068-B2 Rev. 00 Page 8 of 23
RPrepared, RReviewed, RReviewed, RReviewed,
Reviewed, Approved, Approved,

1. OBJECTIVE
The aim of this validation is to ensure that the production process of SANMOL FORTE
Tablet base on the batch record for 120 kg batch size (batch size increased from 20 kg to
120 kg) will produce high degree quality product consistently.

2. SCOPE
This validation is dedicated for SANMOL FORTE Tablet that toll manufacturing product
from PT. Sanbe Farma to PT. Caprifarmindo Laboratories, Cimareme, Padalarang.

The scope of this validation for SANMOL FORTE Tablet covers mixing, granulating,
drying, compressing and stripping.

The validation process have been performed concurrently.

3. VALIDATION TEAM
3.1. Team Member

Function Name / Title

Team Leader Khairudin / Plant Manager PT. Caprifarmindo Labs
Coordinator Novita Purwanti / Process Validation Coordinator
R&D Herwanto / R&D Corp. General Manager
Riny Yunita. H / QC Manager PT. Caprifarmindo Labs
Quality Sumardi / Head of Quality
Rismiatin / QA Manager PT. Caprifarmindo Labs
Engineering Ruchimat Yusuf / Engineering Manager
Mukti Wibowo / Site Validation Coordinator
Validation
Frisky Almuksiti / Validation Engineer
PPIC Purwantoro / PPIC Manager

3.2. Responsibilities
3.2.1. Production Department
Responsible for:
1. Preparing and maintaining the departmental procedures and operator
training programs, which are necessary to ensure that the developed and
implemented standards in the validation runs are followed properly during
routine production.
2. Ordering and maintaining adequate supplies of raw materials and
packaging components to be used for the validation process runs.
3. Preparation, set up and operation of machine and other necessary
production equipment and utensil.
4. Implementing any agreed recommendations that may be made as results of
\\Cimareme\Release\Capri\Val\VAL-PV\Report\MB\068-B2 – Sanmol Forte Tablet Process Validation Report- R00.doc
ORIGINAL Confidential
Document No.VAL-PV/PVR/MB/068-B2 Rev. 00 Page 9 of 23
RPrepared, RReviewed, RReviewed, RReviewed,
Reviewed, Approved, Approved,

this study.
5. Conducting environmental monitoring of temperature and relative
humidity during validation process activity together with validation
department.

3.2.2. QC Department
Responsible for:
1. Preparing all sampling and testing equipment.
2. Testing the samples according to validated analytical method.
3. Conducting investigation with production and validation if there is
any out of specification case.
4. Taking sample according to the sampling point mentioned in this
protocol.

3.2.3. QA Department
Responsible for:
1. Reviewing and approving validation protocol and report for SANMOL
FORTE Tablet.
2. Ensuring that cleaning validation activities conform with quality assurance
requirements.

3.2.4. Validation Department

Responsible for:
1. Preparing validation protocol and report for SANMOL FORTE Tablet.
2. Conducting validation process activities together with the designated
validation team members from Production, QC, R&D and Engineering
departments.
3. Conducting environmental monitoring of temperature and relative
humidity during validation process activity together with production
department.
4. Conducting investigation with R&D, production and QC if there is any out
of specification case.
5. Ensuring that the validation process is executed as approved protocol
agreed.

3.2.5. R&D Department

Responsible for:
1. Preparing the batch record for SANMOL FORTE Tablet.
2. Preparing the product specification and analysis method.
3. Conducting investigation with Validation, production and QC if there is
any out of specification case.

3.2.6. Engineering Department

Responsible for:

\\Cimareme\Release\Capri\Val\VAL-PV\Report\MB\068-B2 – Sanmol Forte Tablet Process Validation Report- R00.doc

ORIGINAL Confidential
Document No.VAL-PV/PVR/MB/068-B2 Rev. 00 Page 10 of 23
RPrepared, RReviewed, RReviewed, RReviewed,
Reviewed, Approved, Approved,

1. Preparing all instruments and equipment needed in the validation process.

2. Preparing and maintaining required standard production operating
conditions and utilities.
3. Repairing and trouble shooting equipment/instrument in case of
breakdown or malfunction.

3.2.7. PPIC Department

Responsible for:
1. Preparing production planning includes validation batches.
2. Maintaining adequate supplies of raw materials and packaging
components to be used for the validation process runs.

4. PROCESS VALIDATION STAGE

4.1. Responsible Personnel

Personnel who are responsible for each step of production process is attached in
attachment 1.

4.2. Starting Material

4.2.1.Formula
Batch Size: 120 kg for 150,000 tablets
Acetaminophen Powder 97.500 kg
Microcrystalline Cellulose 102 qs ad 120 kg 0.720 kg
Croscarmellose Sodium 3.600 kg
Hydroxypropyl Cellulose LM 3.600 kg
Pigment Yellow No. 5 FDC 0.060 kg
Maize Starch 6 kg
Methylparaben 0.084 kg
Propylparaben 0.036 kg
Purified Water 55 Liter
Croscarmellose sodium 3.600 kg
Talc 1.200 kg
Silicon dioxide colloidal 2.400 kg
Magnesium stearate 1.200 kg

4.2.2.Specification & Test Procedure Number of Raw Materials

Raw Material Code Specification

Acetaminophen Powder CP01000223 SP-BB- 061; Rev. 05
Microcrystalline Cellulose 102 qs ad 120 kg CP05000015 SP-BB-M-038; Rev. 05
Croscarmellose Sodium CP05000178 SP-BB- 174; Rev. 03
Hydroxypropyl Cellulose LM CP05000220 SP-BB-H-052; Rev. 05
Pigment Yellow No. 5 FDC CP03000285 SP-BB-T-151; Rev. 05

\\Cimareme\Release\Capri\Val\VAL-PV\Report\MB\068-B2 – Sanmol Forte Tablet Process Validation Report- R00.doc

ORIGINAL Confidential
Document No.VAL-PV/PVR/MB/068-B2 Rev. 00 Page 11 of 23
RPrepared, RReviewed, RReviewed, RReviewed,
Reviewed, Approved, Approved,

Raw Material Code Specification

Maize Starch CP05000270 SP-BB-C-079; Rev. 03
Methylparaben CP05000106 SP-BB-M-004; Rev. 04
Propylparaben CP05000107 SP-BB-P-003; Rev. 04
Purified Water CP08000130 SP-BB-P-429; Rev. 02
Talc CP05000153 SP-BB-T-002; Rev. 05
Silicon Dioxide Colloidal CP05000002 SP-BB-C-123; Rev. 05
Magnesium Stearate CP05000100 SP-BB- 001; Rev. 05

4.2.3. Specification & Test Procedure Number of Packaging Materials

Packaging Material Code Specification

PL2) SANMOL FORTE TABLET (150

CP51000476 SP-BK-P-600; Rev. 00
mm/12 µ PT3)
PL 2) Silver Dull 150 mm/12 µ PT3) CP51000292 SP-BK-P-048; Rev. 00
Folding box SANMOL FORTE TABLET CP55000643 SP-BK-F-600; Rev.00
Brochure SANMOL FORTE TABLET CP54000574 SP-BK-B-600; Rev.00
Master box (D1011-1) CP56000037 SP-BK-M-020; Rev.00
Security Seal Tape 12 mm “SANBE” CP59000024 SP-BK-S-003; Rev.01
Paper plaster 2” CP59000021 SP-BK-P-006; Rev.00

PL = Polycellonium
PT = Plain Transparant

4.2.4. Specification & Test Procedure Number Finished Product

Product Specification & Test

Finished Product
Code Procedure Number
SANMOL FORTE TABLET 01026 SP-OJ-S-600; Rev. 02

4.2.5. Machines/ Equipments

Calibration and qualification of machines/equipments used in production
process are attached in the attachment 2.

\\Cimareme\Release\Capri\Val\VAL-PV\Report\MB\068-B2 – Sanmol Forte Tablet Process Validation Report- R00.doc

ORIGINAL Confidential
Document No.VAL-PV/PVR/MB/068-B2 Rev. 00 Page 12 of 23
RPrepared, RReviewed, RReviewed, RReviewed,
Reviewed, Approved, Approved,

4.3. Room Condition

The environment monitoring results form during processing is attached in the
attachment 3.

\\Cimareme\Release\Capri\Val\VAL-PV\Report\MB\068-B2 – Sanmol Forte Tablet Process Validation Report- R00.doc

ORIGINAL Confidential
Document No.VAL-PV/PVR/MB/068-B2 Rev. 00 Page 13 of 23
RPrepared, RReviewed, RReviewed, RReviewed,
Reviewed, Approved, Approved,

4.4. Process Schematic Flow

\\Cimareme\Release\Capri\Val\VAL-PV\Report\MB\068-B2 – Sanmol Forte Tablet Process Validation Report- R00.doc

ORIGINAL Confidential
Document No.VAL-PV/PVR/MB/068-B2 Rev. 00 Page 14 of 23
RPrepared, RReviewed, RReviewed, RReviewed,
Reviewed, Approved, Approved,

4.5. Production Process, Critical Parameter, Testing Point and Analysis Method

Manufacturing Critical Analysis

Starting Material Equipment Testing Point
Step Parameter Method
 Acetaminophen Weighing Electronic Quantity - Calibration label/ N/A
Powder (97.500 kg) Process (1) Balance Accuracy: certificate
Mettler -Balance checking
 Microcrystalline
Toledo Calibration - The weighing
Cellulose 102 qs ad -Actual result
120 kg (0.720 kg) Weight verification by
 Croscarmellose second person
Sodium (3.600 kg)
 Hydroxypropyl
Cellulose LM
(3.600 kg)
 Pigment Yellow No. 5
FDC (0.060 kg)
 Maize Starch (6 kg)
 Methylparaben
(0.084 kg)
 Propylparaben
(0.036 kg)
 Purified water
(55 Liter)
 Croscarmellose
Sodium (3.600 kg)
 Talc (1.200 kg)
 Silicon Dioxide
Colloidal (2.400 kg)
 Magnesium Stearate
(1.200 kg)
 Acetaminophen Sieving (2A) Screen 2 mm Particle size Visually
Powder (97.500 kg)
 Microcrystalline
Cellulose 102 qs ad Sieving (2B)
120 kg (0.720 kg) Granulator
 Croscarmellose Jaw Chuang
Sodium (3.600 kg) Sieving (2C) OG

 Pigment Yellow No. 5

FDC Sieving (2D) Stainless Mesh 80
(0.060 kg) Steel Sifter Mesh 30
 Croscarmellose
Sodium (3.600 kg)

 Croscarmellose
Sodium (3.600 kg) Sieving (2E) Granulator Screen 2 mm
 Talc (1.200 kg) Jaw Chuang
OG
 Silicon Dioxide
Colloidal (2.400 kg)

\\Cimareme\Release\Capri\Val\VAL-PV\Report\MB\068-B2 – Sanmol Forte Tablet Process Validation Report- R00.doc

ORIGINAL Confidential
Document No.VAL-PV/PVR/MB/068-B2 Rev. 00 Page 15 of 23
RPrepared, RReviewed, RReviewed, RReviewed,
Reviewed, Approved, Approved,

Manufacturing Critical Analysis

Starting Material Equipment Testing Point
Step Parameter Method
 Magnesium Stearate Sieving (2F) Stainless Mesh 30
(1.200 kg) Steel Sifter
 Sieved material 1 st Mixing (3) Super Speed : 95 Homogeneity Visually
from step 2A, 2B, 2C, Mixer rpm
2D (SM-150) Time : 20
minutes
 Suspension Mucilage Container N/A Soluble Visually
preparation Preparation (4) Good mucillago
Purified Water 6 Liter
Maize Starch 6 kg

 Preservatives Solution
preparation
Hot Purified Water 24
Liter
Methylparaben
(0.084 kg)
Propylparaben
(0.036 kg)
 Mixed material Wet granulating Super Granulating 1 Good wet masses Visually
step 3 (5) Mixer Agitator
 Mucilage from (SM-150) speed :
step 4
95 – 98 rpm
Chopper
speed :
450 – 460
rpm
Time : 10
minutes
Granulating 2
Agitator
Purified Water 3 Liter speed :
95 – 98 rpm
Chopper
speed :
450 – 460
rpm
Time : 5
minutes
Granulating 3
Agitator
 Purified Water speed :
3 Liter 95 – 98 rpm
Chopper
speed :
820 – 840
rpm
Time : 5
minutes

\\Cimareme\Release\Capri\Val\VAL-PV\Report\MB\068-B2 – Sanmol Forte Tablet Process Validation Report- R00.doc

ORIGINAL Confidential
Document No.VAL-PV/PVR/MB/068-B2 Rev. 00 Page 16 of 23
RPrepared, RReviewed, RReviewed, RReviewed,
Reviewed, Approved, Approved,

Manufacturing Critical Analysis

Starting Material Equipment Testing Point
Step Parameter Method
Granulating 4
Agitator
speed :
 Purified Water
95 – 98 rpm
3 Liter
Chopper
speed :
820 – 840
rpm
Time : 5
minutes
Granulating 5
Agitator
speed :
95 – 98 rpm
 Purified Water
6 Liter Chopper
speed :
820 – 840
rpm
Time : 5
minutes
 Material from Sieving (6) Granulator Screen 10 Particle size Visually
step 5 Jaw Chuang
OG
 Material from Drying (7) FBD Jaw  Interval Air Moisture content Moisture
step 6 Chuang temperature ≤ 3.0 % content analyser
: 10 min
 Exhaust
Temperature
: 45 °C
 Hot air
temperature
: 60 °C
 Interval
shaking
: 30 sec
 Dried material Sieving (8) Granulator Screen 2 mm Particle size Visually
step 7 Jaw Chuang
OG
 Sieved material 2nd Mixing (9) Bohle  Speed : 6 Homogeneity Visually
from step 2C rpm
 Sieved material  Time : 10
step 8
minutes
 Sieved material 3rd Mixing (10) Bohle  Speed : 6 - Appearance, Visually,
from step 2D rpm color, taste, organoleptic
 Mixed Material odor
 Time : 5
from step 9 - Identification Spectrofotometer
minutes - Assay Spectrofotometer
 Mixed material Compressing Tablet Press Machine Appearance Visual
from step 10 (11) Machine speed (form, color, Organoleptic

\\Cimareme\Release\Capri\Val\VAL-PV\Report\MB\068-B2 – Sanmol Forte Tablet Process Validation Report- R00.doc

ORIGINAL Confidential
Document No.VAL-PV/PVR/MB/068-B2 Rev. 00 Page 17 of 23
RPrepared, RReviewed, RReviewed, RReviewed,
Reviewed, Approved, Approved,

Manufacturing Critical Analysis

Starting Material Equipment Testing Point
Step Parameter Method
Compressing odor, sign)
Force Diameter Diameter tester
Thickness Thickness tester
Weight Electronic
balance
Friability Friability tester
Hardness Hardness Tester
Disintegration Disintegration
time tester
Identification of Spectrofotometer
Acetaminophen
Dissolution of Dissolution tester
Acetaminophen HPLC
Related
Subtances RSD calculation
Uniformity of
dosage units Spectrofotometer
Assay of
Acetaminophen
 Tablets from Stripping (12) Stripping Roller Appearance Visually
step 11 Machine temperature Leak test Vacuum
 Polycellonium chamber
Finished
 Tablet in strip Described in SOP No. SP-OJ-600 Rev. 02
Product Testing

4.6. Sampling Plan

4.6.1. Sampling in FBD Jaw Chuang
The samples in FBD Jaw Chuang are taken after drying process is completed. The
samples are taken from the bottom (2 sampling points), middle (4 sampling
points) and top (4 sampling points) which the sample quantity is 5 g respectively.
Each sample is tested its moisture content.

A
TOP
D
B

C
MIDDLE
E
H
BOTTOM F
G
I

Picture 1. Sampling Point in FBD Jaw Chuang

\\Cimareme\Release\Capri\Val\VAL-PV\Report\MB\068-B2 – Sanmol Forte Tablet Process Validation Report- R00.doc

ORIGINAL Confidential
Document No.VAL-PV/PVR/MB/068-B2 Rev. 00 Page 18 of 23
RPrepared, RReviewed, RReviewed, RReviewed,
Reviewed, Approved, Approved,

4.6.2. Sampling in BOHLE

The samples of bulk product in the BOHLE are taken after the mixing process
with lubricant is completed. The granules samples are taken from the top (2
sampling points), middle (2 sampling points) and bottom (2 sampling points)
which the sample quantity is 15 g respectively. Each sample is analysed its
Acetaminophen concentration. The sampling point in the container mixer Bohle is
shown below:

TOP

MIDDLE B
A

D
C BOTTOM

E F

5.
Picture 2. Sampling Point in BOHLE

5.6.1. Sampling During Tablet Pressing

Sampling during tablet pressing process is divided to be 10 sampling points. The
samples are used for dimension, thickness, hardness, friability, disintegration,
uniformity of dosage unit and assay testing of the tablet. The sampling points and
the samples quantity are shown below :
1. In the beginning of the tablet pressing process, take samples:
 10 tablets as samples for thickness test, weight uniformity and hardness
testing and marked “A”.
 16 tablets as samples for friability and disintegration time and marked
“Beginning”.
 tablets as samples for assay, uniformity of dosage unit testing and
dissolution testing and marked “Beginning”.
2. After tablet pressing machine produce 2,500 tablets, take samples:
 10 tablets for thickness test, weight uniformity and hardness testing and
marked “B”.
3. After tablet pressing machine produce 5,000 tablets, take samples:
 10 tablets for thickness test, weight uniformity and hardness testing and
marked “C”.
4. After tablet pressing machine produce 7,500 tablets, take samples:
 10 tablets for test, weight uniformity and hardness testing and marked “D”.

\\Cimareme\Release\Capri\Val\VAL-PV\Report\MB\068-B2 – Sanmol Forte Tablet Process Validation Report- R00.doc

ORIGINAL Confidential
Document No.VAL-PV/PVR/MB/068-B2 Rev. 00 Page 19 of 23
RPrepared, RReviewed, RReviewed, RReviewed,
Reviewed, Approved, Approved,

5. After tablet pressing machine produce 10,000 tablets, take samples:

 10 tablets for thickness test, weight uniformity and hardness testing and
marked “E”.
6. After tablet pressing machine produce 12,500 tablets, take samples:
 10 tablets as samples for thickness test, weight uniformity and hardness
testing and marked “F”.
 16 tablets as samples for friability and disintegration time and marked
“Middle”.
 42 tablets as samples for assay, uniformity of dosage unit testing and
dissolution testing and marked ‘Middle”.
7. After tablet pressing machine produce 15,000 tablets, take samples:
 10 tablets for thickness test, weight uniformity and hardness testing and
marked “G”.
8. After tablet pressing machine produce 17,500 tablets, take samples:
 10 tablets for thickness test, weight uniformity and hardness testing and
marked “H”.
9. After tablet pressing machine produce 20,000 tablets, take samples:
 10 tablets for thickness test, weight uniformity and hardness testing and
marked “I”.
10. After tablet pressing machine produce 22,500 tablets, take samples:
 10 tablets as samples for thickness test, weight uniformity and hardness
testing and marked “J”.
 16 tablets as samples for friability and disintegration time and marked
“End”.
 42 tablets as samples for assay, uniformity of dosage units testing and
dissolution testing and marked “End”.

5.6.2. Sampling during Stripping

Sampling during stripping process is divided to 9 sampling points for leak testing
during stripping process. Total sample that must be taken for leak testing with
batch size 150,000 tablets is 500 tablets (Military Standard). The sample quantity
for each sampling point is 60 stripped tablets. The test is performed during
stripping process as a part of In Process Control. The sampling points and the
samples quantity are shown below:
1. In the beginning of the stripping process is taken 60 stripped tablets as
samples.
2. After stripping machine produce 15,000 of stripped tablets, 60 stripped tablets
are taken as samples.
3. After stripping machine produce 30,000 of stripped tablets, 60 stripped tablets
are taken as samples.
4. After stripping machine produce 45,000 of stripped tablets, 60 stripped tablets
are taken as samples.
5. After stripping machine produce 60,000 of stripped tablets, 60 stripped tablets
are taken as samples.
6. After stripping machine produce 75,000 of stripped tablets, 60 stripped tablets
are taken as samples.

\\Cimareme\Release\Capri\Val\VAL-PV\Report\MB\068-B2 – Sanmol Forte Tablet Process Validation Report- R00.doc

ORIGINAL Confidential
Document No.VAL-PV/PVR/MB/068-B2 Rev. 00 Page 20 of 23
RPrepared, RReviewed, RReviewed, RReviewed,
Reviewed, Approved, Approved,

7. After stripping machine produce 90,000 of stripped tablets, 60 stripped tablets

are taken as samples.
8. After stripping machine produce 105,000 of stripped tablets, 60 stripped tablets
are taken as samples.
9. After stripping machine produce 120,000 of stripped tablets, 60 stripped tablets
are taken as samples.

4.7. Acceptance Criteria

Acceptance criteria or each critical parameter can be seen in attachment 12.

5. CONCLUSION OF THE PROCESS VALIDATION

5.1. Mixing and Granulating Process
All critical parameters and testing result in mixing and granulating comply with the
acceptance criteria (see discussion).

5.2. Compressing Process

All critical parameters and testing result in compressing process comply with the
acceptance criteria (see discussion).

5.3. Stripping Process

All critical parameters and testing result in stripping process comply with the
acceptance criteria.

The result of comparison between the actual yield and theoretical yield of SANMOL FORTE
Tablet batch number OK8501 is 98.3 %.

All critical point and testing result comply with the acceptance criteria. Based on the
described data above, process validation of SANMOL FORTE Tablet batch number OK8501
has passed the test parameter of finished product. Therefore the result of this validation is
PASS.

6. DISCUSSION
N/A

7. RECOMMENDATION
The batch record can be implemented for routine production.

\\Cimareme\Release\Capri\Val\VAL-PV\Report\MB\068-B2 – Sanmol Forte Tablet Process Validation Report- R00.doc

ORIGINAL Confidential
Document No.VAL-PV/PVR/MB/068-B2 Rev. 00 Page 21 of 23
RPrepared, RReviewed, RReviewed, RReviewed,
Reviewed, Approved, Approved,

8. DECISION

9. PROPOSE OF REVALIDATION
Revalidation is performed if there is change of;
1. Formulation
2. Batch size (if more than 25 % of previous batch)
3. Manufacturing process
4. Equipment
5. Primary packaging material
\\Cimareme\Release\Capri\Val\VAL-PV\Report\MB\068-B2 – Sanmol Forte Tablet Process Validation Report- R00.doc
ORIGINAL Confidential
Document No.VAL-PV/PVR/MB/068-B2 Rev. 00 Page 22 of 23
RPrepared, RReviewed, RReviewed, RReviewed,
Reviewed, Approved, Approved,

10. LISTS OF ENCLOSURE

1. Attachment 1 Responsible Personnel

2. Attachment 2 Machines/ Equipments Qualification
3. Attachment 3 Room Monitoring Result
4. Attachment 4 Weighing Process Record
5. Attachment 5 Sieving Process Record
6. Attachment 6 1st Mixing Process Record
7. Attachment 7 Wet Granulating and Wet Granules Sieving Process Record
8. Attachment 8 Granules Drying and Dried Granules Sieving Process Record
9. Attachment 9 2nd and 3rd Mixing Process Record
10. Attachment 10 Tablet Pressing Process Record
11. Attachment 11 Stripping Process Record
12. Attachment 12 Acceptance Criteria
13. Attachment 13 Process Validation Result
14. Attachment 14 Calculation

11. DEVIATION REPORT

Any deviation from the validation report has to be reported to the validation team and
recorded. Any revise from the validation protocol based on the deviation must be approved by
the validation team.

DEVIATION REPORT

SANMOL FORTE TABLET

Name of Validation:
PROCESS VALIDATION REPORT #OK8501
Deviation description N/A
Proposal to close the
N/A
deviation
Discussion and
N/A
conclusion
Reported by Reviewed by Approved by

( ) ( ) ( )

\\Cimareme\Release\Capri\Val\VAL-PV\Report\MB\068-B2 – Sanmol Forte Tablet Process Validation Report- R00.doc

ORIGINAL Confidential
Document No.VAL-PV/PVR/MB/068-B2 Rev. 00 Page 23 of 23
RPrepared, RReviewed, RReviewed, RReviewed,
Reviewed, Approved, Approved,

12. REVISION HISTORY

Revision
Date Description Originator
No.
00 02 July 2014 Initial Release Frisky Almuksiti

\\Cimareme\Release\Capri\Val\VAL-PV\Report\MB\068-B2 – Sanmol Forte Tablet Process Validation Report- R00.doc